Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVODOPA Cause Wrong technique in product usage process? 196 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 196 reports of Wrong technique in product usage process have been filed in association with LEVODOPA (L-Dopa). This represents 3.0% of all adverse event reports for LEVODOPA.

196
Reports of Wrong technique in product usage process with LEVODOPA
3.0%
of all LEVODOPA reports
0
Deaths
6
Hospitalizations

How Dangerous Is Wrong technique in product usage process From LEVODOPA?

Of the 196 reports, 6 (3.1%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVODOPA. However, 196 reports have been filed with the FAERS database.

What Other Side Effects Does LEVODOPA Cause?

Cough (2,142) Drug ineffective (1,036) Parkinson's disease (761) Device issue (565) Product residue present (534) Device difficult to use (466) Condition aggravated (463) Device use issue (443) Dyskinesia (411) Death (335)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which LEVODOPA Alternatives Have Lower Wrong technique in product usage process Risk?

LEVODOPA vs LEVOFLOXACIN LEVODOPA vs LEVOKETOCONAZOLE LEVODOPA vs LEVOLEUCOVORIN LEVODOPA vs LEVOMEPROMAZINE LEVODOPA vs LEVOMETHADONE

Related Pages

LEVODOPA Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process LEVODOPA Demographics